Capital Peptides
PNC-27 30mg

Advanced / Specialty Compounds · 30mg

PNC-27 30mg

Janoshik-tested · 10 vials per kit

PNC-27 – 30mg is a synthetic research peptide developed for its cellular-targeting and advanced wellness research properties, widely recognized for its potential to support cellular integrity and research-focused applications. Functioning through pathways associated with targeted cellular signaling and membrane interaction—particularly mechanisms linked to cellular integrity support—PNC-27 is studied for its ability to support advanced peptide research pathways. Many users incorporate PNC-27 into their regimen to encourage cellular wellness support and maintain research-focused wellness goals.

Research applications

  • Oncology
Read research overview

Choose pack size

$240

AUD · 1 vial

View COAs

≥98%

Purity

Lyophilised

Format

2–3 wks

Arrival

Research Use Only — Disclaimer

This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.